. ( ) 73 , . 7 '20mg' , , , . 30 ." , " " ' ' " . . , , , - , , , , . . , , . , , , , , , , . 1~3 ''-'' ... '' ... ... 0
· . . , , . 45 55 . . . . , , , , , , , . . . , , . , , . , , , , , , . =(064) 752-8961.
, . () . , . . , . , . , . . . . , , . . 1820, 4560% . . , . 7 .
10 ‘’ . , , , , , , . . . 1...
[= ] (HPV) . . , , . HPV HPV . HPV , HPV 16·18·31·33 . 2·4·27, 1, HPV . . . . , . . " , . " ." . , " . (junsoo@mdtoday.co.kr) [ . - ]
[= ] . (Varicella Zoster Virus; VZV) (AD) (Herpes virus) AD (The journal of Alzheimers Disease) . 95% VZV , VZV . VZV 1(HSV-1) HSV-1 AD . VZV HSV-1 6(mm) . VZV , AD . HSV-1 VZV HSV-1 . H… [+100 chars]
300~400 · 300~400 . , . () , . . . . - . . · . - . . , . , , , · . , . . - . , . . 10% . , . - . () () . , . - . . . . · . . - 20 . . 10 20 . 1621 . . , . . - . … [+98 chars]
10 ‘’ . , , , , , , . . . 1...
. . . [=] . (ACS) , , . (ACS ) () , . 5 2% 43 ACS 2 . 5 . 15226 . , . 5 50 (5 ) 2% . 50 , , , . , , , . (BMI), 2 , , , . (5 ) 29%, 25% . (Understanding risk factors for cancer: Whats new and h… [+113 chars]
Journal of the American Academy of Dermatology 8 . (Alexa Magyari) (U.K. Health Improvement Network) 60~99 1767667 . 1 57 44 . 27% . . , . . “, 1 ” . “ , . ” .
'CP-COV03' '' .CP-COV03 19 '' 8 . 4 6 900/ 1 . 900/ 60 54g , 1/6 9g . CP-COV03 19 2 (900) 10, (1350) 6.7 . (drug repositioning) . CP-COV03 , CP-COV03 () . CP-COV03 '(Long Covid)', 'HPV( )', '… [+169 chars]
[] 11 9 , 1,882 10~20 [= ] 11 SOS 9 . 2011 7 2022 6 SOS , 11 9,050 , 1,973 . SOS 5,155 3,273 1,882 . 20 2,959 10 2,609 30 585 , 20 10 . , 2,348 . 2,126 , , 1,757 . SOS 6 4,615, 5,492 . … [+30 chars]